These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23269414)

  • 21. Validation of high throughput screening of human sera for detection of anti-PA IgG by Enzyme-Linked Immunosorbent Assay (ELISA) as an emergency response to an anthrax incident.
    Semenova VA; Steward-Clark E; Maniatis P; Epperson M; Sabnis A; Schiffer J
    Biologicals; 2017 Jan; 45():61-68. PubMed ID: 27814939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.
    Quinn CP; Dull PM; Semenova V; Li H; Crotty S; Taylor TH; Steward-Clark E; Stamey KL; Schmidt DS; Stinson KW; Freeman AE; Elie CM; Martin SK; Greene C; Aubert RD; Glidewell J; Perkins BA; Ahmed R; Stephens DS
    J Infect Dis; 2004 Oct; 190(7):1228-36. PubMed ID: 15346332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative assessment of anthrax vaccine immunogenicity using the dried blood spot matrix.
    Schiffer JM; Maniatis P; Garza I; Steward-Clark E; Korman LT; Pittman PR; Mei JV; Quinn CP
    Biologicals; 2013 Mar; 41(2):98-103. PubMed ID: 23266055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.
    Gallagher TB; Mellado-Sanchez G; Jorgensen AL; Moore S; Nataro JP; Pasetti MF; Baillie LW
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007644. PubMed ID: 31430284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin.
    Gaur R; Gupta PK; Banerjea AC; Singh Y
    Vaccine; 2002 Jun; 20(21-22):2836-9. PubMed ID: 12034111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An enzyme-linked immunosorbent assay for detecting anthrax antibody in white-tailed deer (Odocoileus virginianus): evaluation of anthrax vaccination and sera from free-ranging deer.
    Peterson MJ; Davis DS; Templeton JW
    J Wildl Dis; 1993 Jan; 29(1):130-5. PubMed ID: 8445773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor.
    Taft SC; Weiss AA
    Clin Vaccine Immunol; 2008 Jan; 15(1):71-5. PubMed ID: 18032590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the human immune response to the UK anthrax vaccine.
    Baillie L; Townend T; Walker N; Eriksson U; Williamson D
    FEMS Immunol Med Microbiol; 2004 Oct; 42(2):267-70. PubMed ID: 15364114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new triple chimeric protein as a high immunogenic antigen against anthrax toxins: theoretical and experimental analyses.
    Abdous M; Hasannia S; Salmanian AH; Shahryar Arab S; Shali A; Alizadeh GA; Hajizadeh A; Khafri A; Mohseni A
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):25-31. PubMed ID: 30621469
    [No Abstract]   [Full Text] [Related]  

  • 31. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
    Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1.
    Karmali MA; Petric M; Winkler M; Bielaszewska M; Brunton J; van de Kar N; Morooka T; Nair GB; Richardson SE; Arbus GS
    J Clin Microbiol; 1994 Jun; 32(6):1457-63. PubMed ID: 8077389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG.
    Semenova VA; Schiffer J; Steward-Clark E; Soroka S; Schmidt DS; Brawner MM; Lyde F; Thompson R; Brown N; Foster L; Fox S; Patel N; Freeman AE; Quinn CP
    J Immunol Methods; 2012 Feb; 376(1-2):97-107. PubMed ID: 22197974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated.
    Dumas EK; Garman L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Choudhari S; Picking WD; James JA; Farris AD
    Vaccine; 2017 Jun; 35(26):3416-3422. PubMed ID: 28504191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibody therapies against anthrax.
    Chen Z; Moayeri M; Purcell R
    Toxins (Basel); 2011 Aug; 3(8):1004-19. PubMed ID: 22069754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity.
    Turnbull PC; Leppla SH; Broster MG; Quinn CP; Melling J
    Med Microbiol Immunol; 1988; 177(5):293-303. PubMed ID: 3139974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of immune response to orally administered Sterne strain 34F2 anthrax vaccine.
    Shakya KP; Hugh-Jones ME; Elzer PH
    Vaccine; 2007 Jul; 25(29):5374-7. PubMed ID: 17555849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor.
    Baillie LW; Huwar TB; Moore S; Mellado-Sanchez G; Rodriguez L; Neeson BN; Flick-Smith HC; Jenner DC; Atkins HS; Ingram RJ; Altmann DM; Nataro JP; Pasetti MF
    Vaccine; 2010 Sep; 28(41):6740-8. PubMed ID: 20691267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
    Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum.
    Semenova VA; Steward-Clark E; Stamey KL; Taylor TH; Schmidt DS; Martin SK; Marano N; Quinn CP
    Clin Diagn Lab Immunol; 2004 Sep; 11(5):919-23. PubMed ID: 15358653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.